Age-related balance impairments caused by vestibular dysfunction affect 35% of U.S. adults aged 40 years and older (58 million Americans). The economic burden includes >$225 billion in lost productivity and reduced quality of life and >$50B/year in fall-related elderly healthcare costs. Today, diagnosing these disruptions requiresexpensive clinical equipment and complex procedures, and treatments to restore balance require surgically implanted electrodes. Neursantys has developed NEURVESTA, a non-invasive wearable device that can detect vestibular-related balance impairments and correct them with a specialized form of neurostimulation know as Electrical Vestibular Stimulation (EVS). EVS can counteract vestibular balance impairments caused by age-related degeneration, injures such as concussions, and neurological conditions such as stroke, Parkinson's disease, and multiple sclerosis.

Apps

Biotechnology

Health Care

Neursantys

Neursantys' headquarters in Calgary, Canada

John Ralston

Prentice Tom

Ryan Peters

Josh Roper

Ruth Anne Eatock

Jocelyn Rempel

Mary Furlong

Maryam Saleh

Andreas Caduff

Description

People (1)

Ryan Peters

Jobs